Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Copenhagen
Clinical trial register · Denmark

Clinical Trials in Copenhagen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 26 Aalborg 17 Odense 17 Herlev 15 Aarhus 15
Narrow the registerReset
Recruitment status
Phase
Site location
Copenhagen26 Aalborg17 Odense17 Herlev15 Aarhus15
All 23 locations
Target enrolment
to

Trials with a site in Copenhagen

26 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
134
Copenhagen
2026-07-06
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
340
Copenhagen, Aarhus Nord, Odense C
2026-05-18
Recruiting
Merck Sharp & Dohme LLC
Phase 2
150
Copenhagen, Odense
2025-12-04
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
50
Copenhagen
2025-05-26
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
Merck Sharp & Dohme LLC
Phase 1/2
90
Copenhagen
2024-08-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Copenhagen, Aarhus, Roskilde, Odense C
2024-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Copenhagen, Odense C
2024-06-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
450
Copenhagen, Aalborg, Odense
2024-05-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Copenhagen, Odense, Vejle
2023-12-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Copenhagen, Aarhus
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Copenhagen, Herlev, Aarhus, Herning, Gandrup, Hjørring, Roskilde, Slagelse
2023-10-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Copenhagen, Aalborg, Odense C
2023-07-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Copenhagen
2023-05-31
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Copenhagen, Odense C
2021-08-12
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/copenhagen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Copenhagen that also match the filters currently applied.

How many clinical trials are recruiting in Copenhagen?

15 of the 26 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Copenhagen), 26 studies
PhaseStudiesRecruitingShare
Phase 315657.7%
Phase 1/25519.2%
Phase 24215.4%
Phase 2/3227.7%

Most active sponsors

Lead sponsors with the most studies (Copenhagen)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC2615
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.